KINRIX

GlaxoSmithKline Biologicals SA🇺🇸 United States

FDA Page

Effective Date: May 14, 2026
Approval ID: 6b5f89e9-1292-4f13-5590-44c874bf299c
Products: 1 registered
Version: 32

Regulatory Information

Labeling Type

VACCINE LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use KINRIX safely and effectively. See full prescribing information for KINRIX. KINRIX (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine) injectable suspension, for intramuscular useInitial U.S. Approval: 2008

Quick Stats

Total Products1

Labelers2

Label Sections34

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.